I used to buy from Peptide Sciences so I was certainly paying a premium for reputation at $20/mg. I think Semaglutide is now at a bit of a premium due to it falling out of favour and most people switching to Triz and Reta. I only take a low dose and am happy to stick with what's working.

There must be an irony that it was Trumps crackdown on peptides, I presume to prop up his prescription company, that forced me to switch to Chinese supply. By doing it all at once it created a critical mass for that market.

▲

rootusrootus 14 hours ago | parent [-]

IIRC the biggest impetus for cracking down was Lilly throwing a fit about the gray market supplying reta well before it even becomes available via the normal channels (who knows when that will be). But as you say, it just pushes people to buy direct from Chinese vendors (and it is basically impossible to stop direct imports like that). Would be safer if more reputable US-based sellers could supply it semi-openly as before. Nexaph is still selling it, but I figure the clock is ticking on that.

	▲	deaux 7 hours ago \| parent [-]
		> and it is basically impossible to stop direct imports like that How so? Is there a particular characteristic of the US that makes it so, or of the channels through which this is done? I get that in general it's impossible as with recreational drugs, but when you look at cocaine then at least to traffick it to most wealthy countries it takes a large amount of resources and is at high risk of getting caught. Which is why they're increasingly starting to use narco submarines. This greatly increases the price of the product. Why can't the same happen to peptide imports?